Future Pharma and Innovations

In general, the last several years have been fruitful for both the pharmaceutical and biotechnology industries. Most crucially, the two segments of the industry have entered a golden age in terms of the growth in the number of new pharmaceuticals that have been approved and are in development.

 

New methods of research and the development of new treatment alternatives, such as biologics, stem cells, and medications for susceptible cancer patients, are responsible for many of these breakthroughs.

 

Due in part to these encouraging developments, public valuations of pharma and biotech businesses as well as M&A requests rose up to August/September of this year. Recent public assessments have changed due to the unfavourable publicity surrounding drug price.